Announcement

New product releasing soon.

BLOOM Arousal Gel    

Newsroom

Insights into LOVE

Welcome to our newsroom where we post news, events, and financial updates.

June 29, 2022

LOVE PHARMA INC. ANNOUNCES SECOND CLOSING OF FINANCING

VANCOUVER, BC, CANADA (June 29, 2022) – LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0), announces it

Read More

June 8, 2022

Love Pharma Inc. Announces First Closing of Financing

VANCOUVER, BC, CANADA (June 8, 2022) – LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0), announces it

Read More

May 6, 2022

Love Pharma Inc. Announces Closing of Financing

VANCOUVER, BC, CANADA (May 6, 2022) – LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0), announces it

Read More

April 5, 2022

Love Pharma Inc. Announces First Closing of Financing

VANCOUVER, BC, CANADA (April 5, 2022) – LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0), announces it

Read More

October 12, 2021

Love Pharma Inc., Announces Listing on Frankfurt Stock Exchange

VANCOUVER, BRITISH COLUMBIA, October 12, 2021 / Love Pharma Inc. (CSE: LUV) (FSE: G1Q0) (the “Company”) a specialized health and

Read More

September 29, 2021

Love Pharma, Inc., Formerly Glenbriar Technologies, Inc., Announces Name Change, Consolidation, and Acquisition of Kick Pharmaceuticals, Inc.

VANCOUVER, BRITISH COLUMBIA, September 29, 2021 / Love Pharma Inc. (CSE: LUV) (the “Company”) announces that it has changed its

Read More
End of Results